The mast cell stabilizer tranilast prevents mast cell activation, blocking the release of chymase and thereby preventing the development of hepatic fibrosis in a rat metabolic syndrome-induced NASH model [38]. The gene discussed is CMA1; the disease is metabolic dysfunction-associated steatohepatitis.